Skip to main content

Antibiotic Resistance Market is Growing Dynamically at a Stagnant CAGR of 5.8% During Forecast to 2025



Market Analysis: 

Antibiotic resistance takes place when the bacteria changes in response to the usage of such medicines. The bacteria become antibiotic-resistant and not humans. These bacteria then may infect humans and are difficult to treat in comparison to non-resistant bacteria. Along with antibiotic resistance, antimicrobial resistance too may take place. Antimicrobial drug resistance encompasses resistance to drugs for treating infections resulting from other microbes such as fungi, viruses, and parasites. 
The Nosocomial Antibiotic Resistance Market Size is likely touch USD 13,146 million at a 5.8% CAGR between 2019- 2025, as per the new Market Research Future’s antibiotic resistance statistics. Antibiotics are medicines that are used for preventing and treating bacterial infections.
Numerous factors are adding to the antibiotic resistance market demand. Such factors, as revealed by the latest MRFR report, include increasing initiatives worldwide to control drug-resistance, rise in clinical developments of antibiotic resistance, increasing prevalence of infectious & chronic disease, and growing antibiotic drug resistance infections. 

On the contrary, the high medical cost may limit the antibiotic resistance industry growth over the forecast period. 

Key Players:

Allecra Therapeutics (US), Procarta Biosystems (England), NEMESIS BIOSCIENCE LTD (UK), Entasis Therapeutics (US), Basilea Pharmaceutica Ltd. (Switzerland), Tetraphase Pharmaceuticals (US), Theravance Biopharma (UK), Seres Therapeutics (US), PARATEK Therapeutics (US), Nabriva Therapeutics plc (Ireland), MELINTA THERAPEUTICS, INC. (US), and Achaogen, Inc. (US)

Market Segmentation:

·         The Market Research Future Report provides an inclusive segmental analysis of the antibiotic resistance market based on end user, pathogen, disease, and drug class. 

·         By drug class, the antibiotic resistance market is segmented into oxazolidinones, lipoglycopeptides, tetracyclines, combination therapies, cephalosporins, and others. Others have again been segmented into vancomycin, sulfonamide, and others.

·         By disease, the antibiotic resistance market is segmented into community-acquired bacterial pneumonia, hospital-acquired bacterial pneumonia/ventilator, acute bacterial skim & skin structure infections, clostridium difficile infections, complicated intra-abdominal infections, bloodstream infections, and complicated urinary tract infection.

·         By pathogen, the antibiotic resistance market is segmented into campylobacter, pneumonia, clostridium difficile, pseudomonas aeruginosa, hemophilus influenza, enterococcus, acinetobacter, streptococcus pneumonia, staphylococcus aureus, and others.

·         By end use, the antibiotic resistance market is segmented into research organizations, hospitals and clinics, and others.

Regional Analysis:

By region, the global antibiotic resistance market report covers the growth opportunities and recent trends across Europe, the Americas, the Asia Pacific (APAC), and the Middle East and Africa (MEA). Of these, the Americas will dominate the market over the forecast period. Factors propelling the antibiotic resistance market growth in the region include rising incidence of infectious diseases, rising adoption of antibiotic resistance, and rapidly growing pharmaceutical sector. 

The global antibiotic resistance market in Europe is predicted to hold the second-largest share during the forecast period for an increase in bacterial infections, rising incidence of infectious diseases, and increasing consumption of antibiotic resistance. 

The global antibiotic resistance market in the APAC region is predicted to grow at a high CAGR over the forecast period for the increasing number of hospital-acquired infections and antibiotic-resistant infections. 

The global antibiotic resistance market in the MEA is predicted to have healthy growth over the forecast period for the increasing consumption of antibiotic resistance and rising healthcare expenditure.

. 


Labels:

Comments

Post a Comment

Popular posts from this blog

Covid 19 Analysis on Respiratory Therapeutic Devices Market Analysis and Forecast to 2023

Market Overview: The Global Respiratory Therapeutic Devices Market is predicted to scale to new heights and expand at a CAGR of 10.8% over the forecast period of 2017-2023, asserts Market Research Future (MRFR) in an in-depth study.                   The growth of the Global Covid 19 Analysis on Respiratory Therapeutic Devices Market Analysis   is primarily led by the recent surge in the incidence of chronic respiratory diseases such as asthma, COPD, and sleep disorder breathing. As per the estimates of the World Health Organization (WHO), approximately 235 Mn people suffered from asthma in 2017 across the globe. The growing burden of chronic respiratory diseases (CRDs) induces strong demand for respiratory therapeutic devices within the market. Moreover, with the increase in the global aging population, there is a greater need for respiratory therapeutic devices.     ...
Post a Comment
Read more

Antibody Drug Conjugate Market is Presumed to Grow at a Reliable CAGR of 19% During Forecast to 2023

Antibody Drug Conjugate Market Analysis: Various factors are adding to the global antibody drug conjugate market share. These factors, as per the new MRFR report, include advances in medical technology, rising cases of cancer, growing obese population, and increasing aging population. Additional factors adding market growth include increasing collaborations between biotechnology companies, biopharmaceuticals, and research institutes, rising R&D on oncology diseases, increasing research on advanced drug discoveries, rising number of research on antibody therapies, and preclinical research. The global Antibody Drug Conjugate Market Share is likely to grow at a 19% CAGR between 2017- 2023 , reveals the new Market Research Future (MRFR) report. Antibody drug conjugates are new-age therapeutic agents that have three parts- a chemical linker to attach cytotoxic agents to antibodies, cytotoxic agents for killing target cancer cells, and specific antibodies for binding. Lymphoma, mult...
Post a Comment
Read more

Desalting and Buffer Exchange Market is Growing at a Healthy CAGR of 10.5% During Forecast to 2023

Market Highlights: The Global Desalting and Buffer Exchange Market is anticipated to have held a market value of USD 615.20 million in the year 2017 and is expected to grow at a CAGR of 10.5% during the forecast period. Desalting and buffer exchange play a key role in biotechnological companies. Buffer exchange is used to place a protein solution into a more suitable buffer before applications such as electrophoresis, ion exchange, affinity chromatography among others. Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/6633 Buffer exchange is the term used when one set of buffer salts in a sample is exchanged by another more appropriate buffer set. The rising demand for monoclonal antibodies, growing research and development expenditure by the biopharmaceutical companies, and rising focus on proteomic and genomic research is anticipated to boost the growth of the market over the forecast period. However, the dearth of skilled professionals is excepted to ...
Post a Comment
Read more